XML 108 R93.htm IDEA: XBRL DOCUMENT v3.22.2
SEGMENT INFORMATION - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Disaggregation of Revenue [Line Items]        
Revenues $ 1,967 $ 2,100 $ 3,885 $ 4,127
Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 884 942 1,728 1,834
Devices        
Disaggregation of Revenue [Line Items]        
Revenues 449 470 907 924
OTC        
Disaggregation of Revenue [Line Items]        
Revenues 400 359 775 706
Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 214 305 435 615
Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 20 24 40 48
Salix        
Disaggregation of Revenue [Line Items]        
Revenues 501 516 965 988
Salix | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 501 514 965 984
Salix | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 0 2 0 4
International        
Disaggregation of Revenue [Line Items]        
Revenues 233 313 477 619
International | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 69 67 134 126
International | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
International | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 35 32 73 57
International | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 122 206 255 418
International | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 7 8 15 18
Diversified Products        
Disaggregation of Revenue [Line Items]        
Revenues 235 264 484 560
Diversified Products | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 197 223 402 465
Diversified Products | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Diversified Products | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 1 2 3 4
Diversified Products | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 31 31 67 78
Diversified Products | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 6 8 12 13
Solta Medical        
Disaggregation of Revenue [Line Items]        
Revenues 57 73 129 145
Solta Medical | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Solta Medical | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 57 73 129 145
Solta Medical | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Solta Medical | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Solta Medical | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0
Bausch + Lomb        
Disaggregation of Revenue [Line Items]        
Revenues 941 934 1,830 1,815
Bausch + Lomb | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 117 138 227 259
Bausch + Lomb | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 392 397 778 779
Bausch + Lomb | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 364 325 699 645
Bausch + Lomb | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 61 68 113 119
Bausch + Lomb | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues $ 7 $ 6 $ 13 $ 13